HCW BIOLOGICS ($HCWB) is expected to release its quarterly earnings data on Tuesday, April 1st after market close, per Finnhub. Analysts are expecting revenue of $7,140,000 and earnings of $0.09 per share.
You can see Quiver Quantitative's $HCWB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HCW BIOLOGICS Hedge Fund Activity
We have seen 4 institutional investors add shares of HCW BIOLOGICS stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 2,023,664 shares (+inf%) to their portfolio in Q4 2024, for an estimated $902,756
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 50,000 shares (-59.0%) from their portfolio in Q4 2024, for an estimated $22,305
- HRT FINANCIAL LP removed 46,497 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $20,742
- XTX TOPCO LTD added 33,999 shares (+inf%) to their portfolio in Q4 2024, for an estimated $15,166
- JANE STREET GROUP, LLC removed 24,137 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $13,019
- VIRTU FINANCIAL LLC added 15,623 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,969
- RENAISSANCE TECHNOLOGIES LLC added 15,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,691
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
